Bacterial	O
peptidoglycan	O
induces	O
CD14	B-protein
-dependent	O
activation	O
of	O
transcription	B-protein
factors	I-protein
CREB/ATF	B-protein
and	O
AP-1	B-protein
.	O

Peptidoglycan	O
(	O
PGN	O
)	O
,	O
the	O
major	O
cell	O
wall	O
component	O
of	O
Gram-positive	O
bacteria	O
,	O
induces	O
secretion	O
of	O
cytokines	B-protein
in	O
macrophages	B-cell_type
through	O
CD14	B-protein
,	O
the	O
pattern	O
recognition	O
receptor	O
that	O
binds	O
lipopolysaccharide	O
and	O
other	O
microbial	O
products	O
.	O

To	O
begin	O
to	O
elucidate	O
the	O
mechanisms	O
that	O
regulate	O
the	O
transcription	O
of	O
cytokine	B-DNA
genes	I-DNA
,	O
we	O
wanted	O
to	O
determine	O
which	O
transcription	B-protein
factors	I-protein
are	O
activated	O
by	O
PGN	O
in	O
mouse	B-cell_line
RAW264.7	I-cell_line
and	O
human	B-cell_line
THP-1	I-cell_line
macrophage	I-cell_line
cells	I-cell_line
.	O

Our	O
results	O
demonstrated	O
that	O
:	O
(	O
i	O
)	O
PGN	O
induced	O
phosphorylation	O
of	O
the	O
transcription	B-protein
factors	I-protein
ATF-1	B-protein
and	O
CREB	B-protein
;	O
(	O
ii	O
)	O
ATF-1	B-protein
and	O
CREB	B-protein
bound	O
DNA	O
as	O
a	O
dimer	O
and	O
induced	O
transcriptional	O
activation	O
of	O
a	O
CRE	B-DNA
reporter	I-DNA
plasmid	I-DNA
,	O
which	O
was	O
inhibited	O
by	O
dominant	O
negative	O
CREB	B-protein
and	O
ATF-1	B-protein
;	O
(	O
iii	O
)	O
PGN	O
induced	O
phosphorylation	O
of	O
c-Jun	B-protein
,	O
protein	O
synthesis	O
of	O
JunB	B-protein
and	O
c-Fos	B-protein
,	O
and	O
transcriptional	O
activation	O
of	O
the	O
AP-1	B-DNA
reporter	I-DNA
plasmid	I-DNA
,	O
which	O
was	O
inhibited	O
by	O
dominant	O
negative	O
c-Fos	B-protein
;	O
and	O
(	O
iv	O
)	O
PGN-induced	O
activation	O
of	O
CREB/ATF	B-protein
and	O
AP-1	B-protein
was	O
mediated	O
through	O
CD14	B-protein
.	O

This	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
activation	O
of	O
CREB/ATF	B-protein
and	O
AP-1	B-protein
transcription	I-protein
factors	I-protein
by	O
PGN	O
or	O
by	O
any	O
other	O
component	O
of	O
Gram-positive	O
bacteria	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

20	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

14012-14020	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Bacterial	NULL
Peptidoglycan	NULL
Induces	NULL
CD14-dependent	NULL
Activation	NULL
of	NULL
Transcription	NULL
Factors	NULL
CREB/ATF	NULL
and	NULL
AP-1*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
17	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
17	NULL
,	NULL
1999	NULL
)	NULL
Dipika	NULL
Guptat	NULL
$	NULL
§	NULL
,	NULL
Qiuling	NULL
Wangt	NULL
,	NULL
Charles	NULL
Vinsont	NULL
,	NULL
and	NULL
Roman	NULL
Dziarskif	NULL
From	NULL
the	NULL
{	NULL
Northwest	NULL
Center	NULL
for	NULL
Medical	NULL
Education	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Gary	NULL
,	NULL
Indiana	NULL
46408	NULL
and	NULL
the	NULL
Laboratory	NULL
of	NULL
Biochemistry	NULL
,	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Peptidoglycan	NULL
(	NULL
PGN	NULL
)	NULL
,	NULL
the	NULL
major	NULL
cell	NULL
wall	NULL
component	NULL
of	NULL
Gram-positive	NULL
bacteria	NULL
,	NULL
induces	NULL
secretion	NULL
of	NULL
cytokines	NULL
in	NULL
macrophages	NULL
through	NULL
CD14	NULL
,	NULL
the	NULL
pattern	NULL
recognition	NULL
receptor	NULL
that	NULL
binds	NULL
lipopolysaccharide	NULL
and	NULL
other	NULL
microbial	NULL
products	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
which	NULL
transcription	NULL
factors	NULL
are	NULL
activated	NULL
by	NULL
PGN	NULL
in	NULL
mouse	NULL
RAW264.7	NULL
and	NULL
human	NULL
THP	NULL
-1	NULL
macrophage	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
demonstrated	NULL
that	NULL
:	NULL
(	NULL
i	NULL
)	NULL
PGN	NULL
induced	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
ATF-1	NULL
and	NULL
CREB	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
ATF-1	NULL
and	NULL
CREB	NULL
bound	NULL
DNA	NULL
as	NULL
a	NULL
dimer	NULL
and	NULL
induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
CRE	NULL
reporter	NULL
plasmid	NULL
,	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
dominant	NULL
negative	NULL
CREB	NULL
and	NULL
ATF-1	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
PGN	NULL
induced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
,	NULL
protein	NULL
synthesis	NULL
of	NULL
JunB	NULL
and	NULL
c-Fos	NULL
,	NULL
and	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
,	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
dominant	NULL
negative	NULL
c-Fos	NULL
;	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
PGN-induced	NULL
activation	NULL
of	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
was	NULL
mediated	NULL
through	NULL
CD14	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
study	NULL
to	NULL
demonstrate	NULL
activation	NULL
of	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
by	NULL
PGN	NULL
or	NULL
by	NULL
any	NULL
other	NULL
component	NULL
of	NULL
Gram-positive	NULL
bacteria	NULL
.	NULL

Peptidoglycan	NULL
(	NULL
PGN	NULL
)	NULL
,	NULL
a	NULL
polymer	NULL
of	NULL
alternating	NULL
GleNAc	NULL
and	NULL
MurNAc	NULL
cross-linked	NULL
by	NULL
short	NULL
peptides	NULL
,	NULL
is	NULL
present	NULL
in	NULL
all	NULL
bacterial	NULL
cell	NULL
walls	NULL
and	NULL
is	NULL
the	NULL
major	NULL
cell	NULL
wall	NULL
component	NULL
of	NULL
Gram-positive	NULL
bacteria	NULL
(	NULL
1	NULL
)	NULL
.	NULL

PGN	NULL
,	NULL
like	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
,	NULL
the	NULL
major	NULL
cell	NULL
wall	NULL
component	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
)	NULL
,	NULL
can	NULL
induce	NULL
all	NULL
major	NULL
signs	NULL
and	NULL
symptoms	NULL
associated	NULL
with	NULL
bacterial	NULL
infections	NULL
,	NULL
including	NULL
fever	NULL
,	NULL
inflammation	NULL
,	NULL
leukopenia	NULL
followed	NULL
by	NULL
leukocytosis	NULL
,	NULL
hypotension	NULL
,	NULL
decreased	NULL
appetite	NULL
,	NULL
decreased	NULL
peripheral	NULL
perfusion	NULL
,	NULL
malaise	NULL
,	NULL
sleepiness	NULL
,	NULL
and	NULL
arthritis	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

PGN	NULL
,	NULL
together	NULL
with	NULL
lipoteichoic	NULL
acid	NULL
,	NULL
also	NULL
induces	NULL
circulatory	NULL
shock	NULL
and	NULL
multiple	NULL
organ	NULL
failure	NULL
(	NULL
5	NULL
)	NULL
.	NULL

These	NULL
clinical	NULL
manifestations	NULL
are	NULL
due	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
host	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
macro-phages	NULL
,	NULL
and	NULL
release	NULL
of	NULL
cytokines	NULL
and	NULL
other	NULL
pro-inflammatory	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
Al28797	NULL
(	NULL
to	NULL
R.	NULL
D.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Northwest	NULL
Center	NULL
for	NULL
Medical	NULL
Education	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
3400	NULL
Broadway	NULL
,	NULL
Gary	NULL
,	NULL
IN	NULL
46408	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
219-980-6557	NULL
;	NULL
Fax	NULL
:	NULL
219-980-6566	NULL
,	NULL
E-mail	NULL
:	NULL
dgupta	NULL
@	NULL
meded.iun.indiana.edu	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PGN	NULL
,	NULL
peptidoglycan	NULL
;	NULL
Ab	NULL
,	NULL
antibody	NULL
;	NULL
AP-1	NULL
,	NULL
activating	NULL
protein-1	NULL
;	NULL
ATF	NULL
,	NULL
activating	NULL
transcription	NULL
factor	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE-binding	NULL
protein	NULL
;	NULL
Egr	NULL
,	NULL
early	NULL
growth	NULL
re-sponse	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
IL-1	NULL
,	NULL
interleukin	NULL
1	NULL
;	NULL
IL-6	NULL
,	NULL
interleukin	NULL
6	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysac-charide	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
ReLPS	NULL
,	NULL
LPS	NULL
from	NULL
S.	NULL
minnesota	NULL
Re	NULL
595	NULL
;	NULL
sPGN	NULL
,	NULL
soluble	NULL
PGN	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
TPA-RE	NULL
,	NULL
12-O-tetradecanoylphorbol-18-acetate	NULL
response	NULL
element	NULL
.	NULL

14012	NULL
molecules	NULL
(	NULL
2-6	NULL
)	NULL
from	NULL
activated	NULL
cells	NULL
.	NULL

Both	NULL
PGN	NULL
(	NULL
3	NULL
,	NULL
7-10	NULL
)	NULL
and	NULL
LPS	NULL
(	NULL
8	NULL
,	NULL
11-15	NULL
)	NULL
activate	NULL
macrophages	NULL
through	NULL
the	NULL
pattern	NULL
recognition	NULL
receptor	NULL
CD14	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
several	NULL
differences	NULL
in	NULL
the	NULL
interaction	NULL
of	NULL
PGN	NULL
and	NULL
LPS	NULL
with	NULL
CD14	NULL
(	NULL
8	NULL
,	NULL
10	NULL
,	NULL
16	NULL
)	NULL
.	NULL

TNF-a	NULL
(	NULL
6	NULL
,	NULL
16	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
7	NULL
,	NULL
16	NULL
)	NULL
are	NULL
the	NULL
main	NULL
cytokines	NULL
released	NULL
from	NULL
PGN-activated	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
culminate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
are	NULL
so	NULL
far	NULL
unknown	NULL
.	NULL

The	NULL
promoters	NULL
for	NULL
these	NULL
cytokine	NULL
genes	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
various	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
CREB	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
PGN	NULL
(	NULL
8	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
known	NULL
if	NULL
PGN	NULL
induces	NULL
activation	NULL
of	NULL
any	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

It	NULL
is	NULL
also	NULL
not	NULL
known	NULL
which	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
PGN-induced	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

The	NULL
CREB/ATF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
leucine	NULL
zipper	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
,	NULL
5	NULL
{	NULL
-TGACGTCA-3	NULL
'	NULL
(	NULL
17	NULL
)	NULL
.	NULL

CREB	NULL
,	NULL
the	NULL
most	NULL
extensively	NULL
studied	NULL
CRE-binding	NULL
protein	NULL
,	NULL
is	NULL
phosphorylated	NULL
at	NULL
serine	NULL
133	NULL
by	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
response	NULL
to	NULL
cAMP	NULL
,	NULL
and	NULL
this	NULL
leads	NULL
to	NULL
transcriptional	NULL
activation	NULL
(	NULL
17	NULL
)	NULL
of	NULL
genes	NULL
whose	NULL
promoters	NULL
contain	NULL
the	NULL
CRE	NULL
sequence	NULL
.	NULL

There	NULL
are	NULL
other	NULL
signaling	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
CREB	NULL
,	NULL
such	NULL
as	NULL
calmodulin	NULL
kinase	NULL
,	NULL
which	NULL
phosphorylates	NULL
CREB	NULL
in	NULL
response	NULL
to	NULL
increased	NULL
intracellular	NULL
Ca**	NULL
(	NULL
17	NULL
)	NULL
,	NULL
or	NULL
RSK2	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinases	NULL
(	NULL
18	NULL
)	NULL
.	NULL

ATF-1	NULL
,	NULL
another	NULL
member	NULL
of	NULL
this	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
has	NULL
significant	NULL
sequence	NULL
similarity	NULL
to	NULL
CREB	NULL
,	NULL
including	NULL
a	NULL
phosphorylation	NULL
domain	NULL
(	NULL
17	NULL
)	NULL
.	NULL

ATF-1	NULL
forms	NULL
heterodimers	NULL
only	NULL
with	NULL
CREB	NULL
;	NULL
however	NULL
,	NULL
the	NULL
other	NULL
ATF	NULL
proteins	NULL
can	NULL
also	NULL
form	NULL
heterodimers	NULL
with	NULL
specific	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
different	NULL
heterodimers	NULL
may	NULL
bind	NULL
variant	NULL
CRE	NULL
sequences	NULL
,	NULL
thus	NULL
increasing	NULL
the	NULL
number	NULL
of	NULL
potential	NULL
regulatory	NULL
mechanisms	NULL
.	NULL

The	NULL
AP-1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
consists	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
the	NULL
12-O-tetradeca-noylphorbol-13-acetate	NULL
response	NULL
element	NULL
(	NULL
TPA-RE	NULL
)	NULL
,	NULL
5'-TGAC-TCA-3	NULL
'	NULL
and	NULL
induce	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
many	NULL
different	NULL
stimuli	NULL
,	NULL
including	NULL
phorbol	NULL
esters	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
bind	NULL
DNA	NULL
as	NULL
dimers	NULL
,	NULL
which	NULL
are	NULL
formed	NULL
through	NULL
leucine	NULL
zippers	NULL
.	NULL

The	NULL
Jun	NULL
proteins	NULL
can	NULL
bind	NULL
DNA	NULL
as	NULL
homodimers	NULL
or	NULL
as	NULL
heterodimers	NULL
with	NULL
Fos	NULL
proteins	NULL
;	NULL
however	NULL
,	NULL
the	NULL
Fos	NULL
proteins	NULL
can	NULL
only	NULL
bind	NULL
DNA	NULL
as	NULL
heterodimers	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
forming	NULL
heterodimers	NULL
within	NULL
the	NULL
AP-1	NULL
family	NULL
,	NULL
Jun	NULL
proteins	NULL
can	NULL
heterodimerize	NULL
with	NULL
certain	NULL
members	NULL
of	NULL
other	NULL
transcription	NULL
factor	NULL
families	NULL
,	NULL
such	NULL
as	NULL
ATF	NULL
and	NULL
C/EBP	NULL
$	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Different	NULL
dimers	NULL
can	NULL
bind	NULL
different	NULL
sequences	NULL
,	NULL
e.g	NULL
.	NULL

Jun-Jun	NULL
and	NULL
Jun-Fos	NULL
dimers	NULL
preferentially	NULL
bind	NULL
TPA-RE	NULL
,	NULL
while	NULL
Jun-ATF	NULL
dimers	NULL
prefer	NULL
to	NULL
bind	NULL
the	NULL
CRE	NULL
sequence	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
objective	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
:	NULL
(	NULL
i	NULL
)	NULL
determine	NULL
if	NULL
PGN	NULL
activates	NULL
the	NULL
transcription	NULL
factors	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
identify	NULL
the	NULL
specific	NULL
members	NULL
of	NULL
these	NULL
two	NULL
families	NULL
of	NULL
transcrip-	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
tion	NULL
factors	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
PGN	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
determine	NULL
if	NULL
this	NULL
activation	NULL
is	NULL
CD14-dependent	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Soluble	NULL
PGN	NULL
(	NULL
sPGN	NULL
)	NULL
,	NULL
a	NULL
soluble	NULL
polymeric	NULL
form	NULL
of	NULL
PGN	NULL
,	NULL
was	NULL
isolated	NULL
from	NULL
Staphylococcus	NULL
aureus	NULL
Rb	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
penicillin	NULL
(	NULL
20	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
vancomycin	NULL
affinity	NULL
chromatography	NULL
,	NULL
and	NULL
its	NULL
purity	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

sPGN	NULL
contained	NULL
<	NULL
24	NULL
pg	NULL
of	NULL
endotoxin/mg	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
Limulus	NULL
lysate	NULL
assay	NULL
(	NULL
21	NULL
)	NULL
.	NULL

LPS	NULL
from	NULL
Salmonella	NULL
minnesota	NULL
Re	NULL
595	NULL
(	NULL
ReLPS	NULL
,	NULL
a	NULL
minimal	NULL
naturally	NULL
occurring	NULL
endotoxic	NULL
structure	NULL
of	NULL
LPS	NULL
)	NULL
,	NULL
obtained	NULL
by	NULL
phenol-chloroform-petro-leum	NULL
ether	NULL
extraction	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

All	NULL
other	NULL
chemicals	NULL
were	NULL
from	NULL
Sigma	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

Cells-Murine	NULL
macrophage	NULL
RAW264.7	NULL
cell	NULL
line	NULL
,	NULL
obtained	NULL
from	NULL
ATCC	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
was	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
defined	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
;	NULL
endotoxin	NULL
content	NULL
<	NULL
6	NULL
pg/ml	NULL
)	NULL
.	NULL

Human	NULL
monocytic	NULL
THP-1	NULL
cell	NULL
line	NULL
,	NULL
obtained	NULL
from	NULL
ATCC	NULL
,	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
defined	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
differentiate	NULL
for	NULL
72	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
nM	NULL
1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
(	NULL
Biomol	NULL
,	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
and	NULL
Western	NULL
Blots-RAW	NULL
264.7	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
0.85-0.4	NULL
X	NULL
10°/ml	NULL
in	NULL
24-well	NULL
plates	NULL
(	NULL
2	NULL
ml/well	NULL
)	NULL
and	NULL
cultured	NULL
for	NULL
16-20	NULL
h.	NULL
THP-1	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
0.15	NULL
X	NULL
10°/ml	NULL
in	NULL
24-well	NULL
plates	NULL
(	NULL
2	NULL
ml/well	NULL
)	NULL
and	NULL
allowed	NULL
to	NULL
differentiate	NULL
as	NULL
above	NULL
for	NULL
72	NULL
h.	NULL
All	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
the	NULL
stimulants	NULL
indicated	NULL
under	NULL
``	NULL
Results	NULL
``	NULL
and	NULL
then	NULL
washed	NULL
and	NULL
lysed	NULL
as	NULL
before	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
ug/ml	NULL
polymyxin	NULL
B	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
added	NULL
to	NULL
cells	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
ug/ml	NULL
anti-CD14	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
MY4	NULL
(	NULL
Coulter	NULL
,	NULL
Hi-aleah	NULL
,	NULL
FL	NULL
)	NULL
or	NULL
MEM18	NULL
(	NULL
Sanbio-Monosan	NULL
,	NULL
Uden	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
or	NULL
the	NULL
isotype	NULL
control	NULL
IgG2b	NULL
(	NULL
clone	NULL
MPC-11	NULL
;	NULL
Coulter	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
before	NULL
stimulation	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
separated	NULL
on	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon	NULL
P	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
0.5	NULL
ug/ml	NULL
rabbit	NULL
anti-pCREB	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
the	NULL
ECL	NULL
system	NULL
.	NULL

This	NULL
antibody	NULL
specifically	NULL
recognizes	NULL
the	NULL
phosphorylated	NULL
forms	NULL
of	NULL
both	NULL
ATF-1	NULL
and	NULL
CREB	NULL
.	NULL

Control	NULL
blots	NULL
were	NULL
done	NULL
with	NULL
0.5	NULL
ug/ml	NULL
rabbit	NULL
anti-CREB	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
or	NULL
rabbit	NULL
anti-ATF-1	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
recognize	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
forms	NULL
of	NULL
CREB	NULL
or	NULL
ATF-1	NULL
,	NULL
respectively	NULL
.	NULL

Activation	NULL
of	NULL
AP-1	NULL
and	NULL
Western	NULL
Blots-Cells	NULL
were	NULL
cultured	NULL
,	NULL
acti-vated	NULL
,	NULL
and	NULL
lysed	NULL
as	NULL
described	NULL
for	NULL
ATF-1/CREB	NULL
.	NULL

Phosphorylation	NULL
of	NULL
c-Jun	NULL
protein	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
generated	NULL
against	NULL
a	NULL
c-Jun	NULL
peptide	NULL
containing	NULL
phosphorylated	NULL
serine	NULL
63	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Nonphosphorylated	NULL
c-Jun	NULL
,	NULL
Jun	NULL
B	NULL
,	NULL
Jun	NULL
D	NULL
,	NULL
and	NULL
c-Fos	NULL
were	NULL
also	NULL
detected	NULL
by	NULL
Western	NULL
blots	NULL
using	NULL
antibodies	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Enzyme	NULL
Digestions-30-ug	NULL
aliquots	NULL
of	NULL
sPGN	NULL
biosynthetically	NULL
labeled	NULL
with	NULL
[	NULL
``	NULL
Clalanine	NULL
(	NULL
20	NULL
)	NULL
were	NULL
digested	NULL
for	NULL
72	NULL
h	NULL
at	NULL
87°C	NULL
with	NULL
1	NULL
mg/ml	NULL
affinity-purified	NULL
lysostaphin	NULL
or	NULL
1	NULL
mg/ml	NULL
lysozyme	NULL
(	NULL
Grade	NULL
I	NULL
from	NULL
chicken	NULL
egg	NULL
,	NULL
from	NULL
Sigma	NULL
)	NULL
,	NULL
or	NULL
buffer	NULL
alone	NULL
(	NULL
as	NULL
a	NULL
control	NULL
)	NULL
,	NULL
and	NULL
were	NULL
dialyzed	NULL
four	NULL
times	NULL
(	NULL
10-12-kDa	NULL
cut-off	NULL
)	NULL
against	NULL
Dulbecco	NULL
's	NULL
phosphate-buffered	NULL
saline	NULL
at	NULL
4	NULL
°C	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
digestion	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
amount	NULL
of	NULL
*C	NULL
remaining	NULL
in	NULL
the	NULL
samples	NULL
after	NULL
dialysis	NULL
.	NULL

Phosphatase	NULL
Treatment-Stimulated	NULL
and	NULL
control	NULL
RAW264.7	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
three	NULL
different	NULL
buffers	NULL
depending	NULL
on	NULL
the	NULL
phosphatase	NULL
treatment	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
first	NULL
group	NULL
of	NULL
cells	NULL
was	NULL
lysed	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
as	NULL
above	NULL
with	NULL
0.8	NULL
%	NULL
Nonidet	NULL
P-40	NULL
for	NULL
control	NULL
samples	NULL
.	NULL

The	NULL
second	NULL
group	NULL
of	NULL
cells	NULL
was	NULL
lysed	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.8	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
250	NULL
units/ml	NULL
alkaline	NULL
phosphatase	NULL
for	NULL
15	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
.	NULL

The	NULL
third	NULL
group	NULL
of	NULL
cells	NULL
was	NULL
lysed	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
MnCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
with	NULL
0.8	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1.0	NULL
nM	NULL
okadaic	NULL
acid	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
2.9	NULL
units/ml	NULL
protein	NULL
phosphatase	NULL
2A	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
final	NULL
Nonidet	NULL
P-40	NULL
concentration	NULL
in	NULL
all	NULL
samples	NULL
was	NULL
0.6	NULL
%	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
separated	NULL
on	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
for	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
c-Jun	NULL
by	NULL
Western	NULL
blots	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
above	NULL
for	NULL
Western	NULL
blots	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
different	NULL
antibodies	NULL
as	NULL
indicated	NULL
under	NULL
``	NULL
Results	NULL
,	NULL
``	NULL
for	NULL
20	NULL
min	NULL
at	NULL
22	NULL
°C	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
*°P-labeled	NULL
oligonucleotide	NULL
containing	NULL
consensus	NULL
CRE	NULL
(	NULL
17	NULL
)	NULL
or	NULL
TPA-RE	NULL
(	NULL
19	NULL
)	NULL
binding	NULL
sites	NULL
(	NULL
AGAGATTGCCTGACGTCAGAGAG	NULL
and	NULL
AGCTTGATGACT-CAGCCG	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
22°C	NULL
.	NULL

Anti-Jun	NULL
antibody	NULL
was	NULL
14013	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
and	NULL
all	NULL
other	NULL
antibodies	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
as	NULL
described	NULL
above	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
preincubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
or	NULL
nonspecific	NULL
oligonucleotide	NULL
for	NULL
20	NULL
min	NULL
at	NULL
22	NULL
°C	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Transfection	NULL
and	NULL
Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
and	NULL
Luciferase	NULL
Assays-RAW264.7	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
0.85-0.4	NULL
X	NULL
10°/ml	NULL
in	NULL
six-well	NULL
plates	NULL
(	NULL
2	NULL
ml/well	NULL
)	NULL
for	NULL
16-20	NULL
h	NULL
and	NULL
transfected	NULL
with	NULL
200	NULL
ug/ml	NULL
DEAE-dextran	NULL
and	NULL
DNA	NULL
(	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
was	NULL
optimized	NULL
for	NULL
different	NULL
plasmids	NULL
and	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
)	NULL
.	NULL

The	NULL
following	NULL
plasmids	NULL
were	NULL
used	NULL
for	NULL
transfections	NULL
:	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
(	NULL
28	NULL
)	NULL
,	NULL
A-CREB	NULL
(	NULL
24	NULL
)	NULL
,	NULL
pAP1-Luc	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
2xAP1-Lue	NULL
(	NULL
25	NULL
)	NULL
,	NULL
-78Col-Lue	NULL
(	NULL
26	NULL
)	NULL
,	NULL
-60Col-Lue	NULL
(	NULL
26	NULL
)	NULL
,	NULL
A-Fos	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
A-ATF1	NULL
,	NULL
which	NULL
was	NULL
constructed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
24-48	NULL
h	NULL
and	NULL
then	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Lysates	NULL
were	NULL
prepared	NULL
and	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
the	NULL
Luciferase	NULL
Reporter	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
or	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

RESULTS	NULL
sPGN	NULL
Induces	NULL
Phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB-Acti-vation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
CREB	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
at	NULL
serine	NULL
183	NULL
.	NULL

ATF-1	NULL
,	NULL
also	NULL
a	NULL
CRE-binding	NULL
protein	NULL
,	NULL
has	NULL
extensive	NULL
homology	NULL
to	NULL
CREB	NULL
,	NULL
including	NULL
a	NULL
conserved	NULL
phosphorylation	NULL
site	NULL
.	NULL

We	NULL
tested	NULL
if	NULL
sPGN	NULL
induces	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
ATF-1	NULL
in	NULL
RAW264.7	NULL
cells	NULL
,	NULL
using	NULL
an	NULL
antibody	NULL
that	NULL
specifically	NULL
recognizes	NULL
both	NULL
phosphorylated	NULL
CREB	NULL
and	NULL
phosphorylated	NULL
ATF-1	NULL
.	NULL

sPGN	NULL
induced	NULL
rapid	NULL
and	NULL
transient	NULL
dose-dependent	NULL
phosphorylation	NULL
of	NULL
both	NULL
ATF-1	NULL
and	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

The	NULL
control	NULL
stimulant	NULL
,	NULL
ReLPS	NULL
,	NULL
also	NULL
induced	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
those	NULL
seen	NULL
with	NULL
sPGN	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
was	NULL
stronger	NULL
than	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
for	NULL
both	NULL
stimu-lants	NULL
.	NULL

Identical	NULL
samples	NULL
analyzed	NULL
with	NULL
antibodies	NULL
that	NULL
recognize	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
ATF-1	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
showed	NULL
equal	NULL
amounts	NULL
of	NULL
CREB	NULL
and	NULL
ATF-1	NULL
protein	NULL
present	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

sPGN-induced	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
polymyxin	NULL
B	NULL
(	NULL
an	NULL
antibiotic	NULL
that	NULL
binds	NULL
LPS	NULL
and	NULL
inhibits	NULL
its	NULL
biologic	NULL
effects	NULL
)	NULL
,	NULL
unlike	NULL
the	NULL
induction	NULL
by	NULL
ReLPS	NULL
,	NULL
which	NULL
was	NULL
almost	NULL
completely	NULL
inhibited	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

This	NULL
confirms	NULL
that	NULL
the	NULL
sPGN-induced	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
endotoxin	NULL
contam-ination	NULL
.	NULL

In	NULL
control	NULL
experiments	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
total	NULL
(	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

12	NULL
)	NULL
and	NULL
ATF-1	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
proteins	NULL
were	NULL
the	NULL
same	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

Composition	NULL
of	NULL
CREB/	NULL
ATF	NULL
Complexes	NULL
That	NULL
Bind	NULL
CRE	NULL
Consensus	NULL
Sequence-To	NULL
determine	NULL
if	NULL
CREB	NULL
and	NULL
ATF-1	NULL
bind	NULL
to	NULL
the	NULL
CRE	NULL
sequence	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
CRE-binding	NULL
complexes	NULL
,	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CRE	NULL
consensus	NULL
sequence	NULL
and	NULL
antibodies	NULL
to	NULL
specific	NULL
proteins	NULL
in	NULL
the	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
AP-1	NULL
family	NULL
was	NULL
included	NULL
because	NULL
Jun	NULL
proteins	NULL
also	NULL
bind	NULL
CRE	NULL
sequence	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
RAW264.7	NULL
cells	NULL
contained	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
CRE	NULL
consensus	NULL
site	NULL
(	NULL
the	NULL
protein-DNA	NULL
complex	NULL
ran	NULL
higher	NULL
than	NULL
the	NULL
free	NULL
oligonucleotide	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
between	NULL
stimulated	NULL
and	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
compare	NULL
lanes	NULL
I	NULL
for	NULL
Nil	NULL
,	NULL
sPGN	NULL
,	NULL
and	NULL
ReLPS	NULL
samples	NULL
)	NULL
.	NULL

This	NULL
is	NULL
characteristic	NULL
of	NULL
the	NULL
protein	NULL
complex	NULL
that	NULL
binds	NULL
CRE	NULL
sequence	NULL
,	NULL
where	NULL
activation	NULL
does	NULL
not	NULL
result	NULL
in	NULL
a	NULL
change	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
proteins	NULL
,	NULL
but	NULL
induces	NULL
phosphorylation	NULL
of	NULL
the	NULL
already	NULL
bound	NULL
proteins	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
cells	NULL
were	NULL
supershifted	NULL
by	NULL
antibodies	NULL
against	NULL
CREB-1	NULL
,	NULL
pCREB	NULL
,	NULL
and	NULL
ATF-1	NULL
,	NULL
but	NULL
not	NULL
against	NULL
ATF-2	NULL
,	NULL
Jun	NULL
,	NULL
and	NULL
c-Fos	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
protein	NULL
dimer	NULL
that	NULL
binds	NULL
CRE	NULL
consensus	NULL
sequence	NULL
in	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
RAW264.7	NULL
cells	NULL
consists	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
.	NULL

There	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
14014	NULL
A	NULL
anti-pCREB	NULL
and	NULL
anti-pATF-1	NULL
Blot	NULL
D	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
anti-pCREB	NULL
and	NULL
anti-pATF-1	NULL
Blot	NULL
sPGN	NULL
_ReLPS	NULL
sPGN	NULL
_	NULL
ReLPS	NULL
>	NULL
p	NULL
Mi	NULL
©	NULL
o	NULL
o	NULL
w	NULL
o	NULL
o	NULL
—pgfml	NULL
__ngfn1l	NULL
E	NULL
d	NULL
in	NULL
o	NULL
-	NULL
m	NULL
©	NULL
o	NULL
w	NULL
-	NULL
a	NULL
6	NULL
0	NULL
a	NULL
C	NULL
o	NULL
o	NULL
-	NULL
Fd	NULL
--	NULL
--	NULL
al	NULL
-	NULL
ProlymyxinB	NULL
--	NULL
+-++	NULL
30-	NULL
so-56	NULL
-	NULL
56	NULL
43	NULL
-	NULL
seuth	NULL
=	NULL
_	NULL
<	NULL
&	NULL
t	NULL
+	NULL
<	NULL
-	NULL
pCREB	NULL
43	NULL
-	NULL
a	NULL
Ath	NULL
Ah	NULL
to	NULL
th	NULL
th	NULL
.	NULL

*	NULL
<	NULL
-	NULL
pCREB	NULL
«	NULL
a	NULL
-	NULL
©	NULL
@	NULL
»	NULL
<	NULL
-	NULL
pATF-1	NULL
*	NULL
am	NULL
am	NULL
ah	NULL
-	NULL
a	NULL
®	NULL
a	NULL
a	NULL
t	NULL
-	NULL
<	NULL
-	NULL
pATF-1	NULL
34	NULL
-	NULL
44	NULL
.	NULL

anti-CREB	NULL
Blot	NULL
B	NULL
anti-CREB	NULL
Blot	NULL
E	NULL
sPGN	NULL
ReLPS	NULL
w	NULL
_ReLPS	NULL
ag/mt	NULL
--	NULL
ngim	NULL
ae	NULL
A.	NULL
Min	NULL
o	NULL
2	NULL
8	NULL
$	NULL
o	NULL
w	NULL
2	NULL
8	NULL
8	NULL
a	NULL
5	NULL
&	NULL
0	NULL
a	NULL
5	NULL
>	NULL
6	NULL
tems	NULL
memes	NULL
132-	NULL
sezarssesz2f	NULL
Polymyxin	NULL
B	NULL
--	NULL
+-++	NULL
90	NULL
>	NULL
go-	NULL
%	NULL
dn	NULL
aas	NULL
ams	NULL
am	NULL
ds	NULL
:	NULL
**	NULL
44+	NULL
56	NULL
-	NULL
-	NULL
enanemmane	NULL
<	NULL
n	NULL
an	NULL
an	NULL
at	NULL
dt	NULL
t	NULL
43	NULL
m	NULL
as	NULL
©	NULL
a	NULL
a	NULL
&	NULL
@	NULL
@	NULL
*	NULL
_	NULL
<	NULL
-CREB	NULL
as	NULL
os	NULL
tice	NULL
cic	NULL
.	NULL

ali	NULL
sass	NULL
.	NULL

Aite	NULL
alts	NULL
At	NULL
Ath	NULL
At	NULL
M	NULL
th	NULL
Mh	NULL
ch	NULL
th	NULL
.	NULL

A	NULL
am	NULL
-	NULL
<	NULL
-	NULL
CREB	NULL
34	NULL
-	NULL
34	NULL
C	NULL
anti-ATF-1	NULL
Blot	NULL
sPGN	NULL
-	NULL
ReLPS	NULL
Min	NULL
o	NULL
e	NULL
3	NULL
3	NULL
0	NULL
u	NULL
if	NULL
3	NULL
3	NULL
132-90-	NULL
<	NULL
~	NULL
a	NULL
a	NULL
@	NULL
@	NULL
@	NULL
*	NULL
56	NULL
43	NULL
e	NULL
%	NULL
6	NULL
e	NULL
6	NULL
@	NULL
@	NULL
@	NULL
®	NULL
|	NULL
<	NULL
--	NULL
ATF-1	NULL
34	NULL
Fig	NULL
.	NULL

1.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
:	NULL
time	NULL
kinetics	NULL
,	NULL
dose	NULL
response	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
polymyxin	NULL
B.	NULL
RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
total	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blots	NULL
for	NULL
:	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
using	NULL
an	NULL
anti-phosphorylated	NULL
CREB	NULL
Ab	NULL
(	NULL
4	NULL
)	NULL
,	NULL
total	NULL
(	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
CREB	NULL
using	NULL
an	NULL
anti-CREB	NULL
Ab	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
total	NULL
ATF-1	NULL
protein	NULL
using	NULL
an	NULL
anti-ATF-1	NULL
Ab	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
for	NULL
80	NULL
min	NULL
.	NULL

Cells	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
polymyxin	NULL
B	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
(	NULL
D	NULL
)	NULL
or	NULL
total	NULL
CREB	NULL
(	NULL
E	NULL
)	NULL
.	NULL

pCREB	NULL
,	NULL
pATF-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
ATF-1	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
;	NULL
all	NULL
other	NULL
bands	NULL
are	NULL
nonspecific	NULL
.	NULL

The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

were	NULL
no	NULL
qualitative	NULL
differences	NULL
in	NULL
the	NULL
specific	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
CRE	NULL
site	NULL
between	NULL
stimulated	NULL
and	NULL
nonstimulated	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
there	NULL
was	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
CREB	NULL
and	NULL
pCREB	NULL
in	NULL
the	NULL
bound	NULL
complex	NULL
between	NULL
stimulated	NULL
and	NULL
nonstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
pCREB	NULL
increased	NULL
upon	NULL
stimulation	NULL
by	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
,	NULL
as	NULL
the	NULL
antibodies	NULL
against	NULL
pCREB	NULL
caused	NULL
a	NULL
complete	NULL
shift	NULL
of	NULL
the	NULL
protein-oligonu-cleotide	NULL
complex	NULL
from	NULL
the	NULL
stimulated	NULL
cells	NULL
(	NULL
compare	NULL
the	NULL
pCREB	NULL
lanes	NULL
between	NULL
stimulated	NULL
and	NULL
control	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
upon	NULL
stimulation	NULL
DNA-bound	NULL
CREB	NULL
undergoes	NULL
phosphorylation	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
CREB	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
sequence	NULL
was	NULL
confirmed	NULL
using	NULL
excess	NULL
unlabeled	NULL
specific	NULL
and	NULL
nonspecific	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
cells	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
oligonucleotide	NULL
carrying	NULL
CRE	NULL
sequence	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
oligonucleotide	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
oligonucleotide	NULL
with	NULL
no	NULL
CRE	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
the	NULL
CRE	NULL
oligonucleotide	NULL
specifically	NULL
recognize	NULL
the	NULL
CRE	NULL
sequence	NULL
.	NULL

sPGN	NULL
Induces	NULL
Transactivation	NULL
of	NULL
a	NULL
CREB-regulated	NULL
Gene	NULL
That	NULL
Is	NULL
Inhibited	NULL
by	NULL
Dominant	NULL
Negative	NULL
CREB	NULL
and	NULL
Dominant	NULL
Negative	NULL
ATF-1-To	NULL
determine	NULL
if	NULL
sPGN-	NULL
or	NULL
ReLPS-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
ATF-1	NULL
results	NULL
in	NULL
functional	NULL
activation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
transfected	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
A	NULL
NIL	NULL
sPGN	NULL
ReLPS	NULL
m	NULL
«	NULL
a	NULL
2m	NULL
wr	NULL
Go	NULL
a	NULL
2	NULL
m	NULL
wo	NULL
a	NULL
2	NULL
mu-	NULL
Oo	NULL
s	NULL
-	NULL
-	NULL
TW	NULL
#	NULL
Edue	NULL
?	NULL

Antibody	NULL
$	NULL
$	NULL
Wi	NULL
}	NULL
!	NULL

4	NULL
U	NULL
+-w	NULL
t	NULL
Uit	NULL
us	NULL
19	NULL
W	NULL
w	NULL
w	NULL
u	NULL
-	NULL
(	NULL
»	NULL
4	NULL
lb	NULL
b	NULL
Wt	NULL
s	NULL
5	NULL
85	NULL
bk	NULL
w	NULL
has	NULL
|||	NULL
‘	NULL
Il||.l|||||	NULL
‘	NULL
x	NULL
bids	NULL
nul	NULL
dct	NULL
dud	NULL
hak	NULL
ua	NULL
)	NULL
--	NULL
Ahoi	NULL
B	NULL
sPGN	NULL
ReLPS	NULL
Competitor	NULL
CRE	NULL
-	NULL
Ns	NULL
che	NULL
-	NULL
Ns	NULL
a	NULL
e	NULL
§	NULL
ue	NULL
S	NULL
a	NULL
e	NULL
Se	NULL
eS	NULL
Fold	NULL
Excess	NULL
-	NULL
o	NULL
@	NULL
ara	NULL
i-	NULL
a	NULL
&	NULL
in	NULL
-	NULL
@	NULL
i	NULL
in	NULL
r	NULL
-	NULL
Litbbclit	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

CREB	NULL
and	NULL
ATF-1	NULL
bind	NULL
to	NULL
CRE	NULL
consensus	NULL
sequence	NULL
in	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
for	NULL
30	NULL
min	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
indicated	NULL
Abs	NULL
for	NULL
20	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
80-min	NULL
incubation	NULL
with	NULL
a	NULL
radioactively	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
CRE	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
shift	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
upon	NULL
Ab	NULL
binding	NULL
.	NULL

B	NULL
,	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
CRE	NULL
sites	NULL
was	NULL
demonstrated	NULL
using	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
(	NULL
CRE	NULL
)	NULL
and	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
oligonucleotides	NULL
.	NULL

The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

RAW264.7	NULL
cells	NULL
with	NULL
the	NULL
plasmid	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
or	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
and	NULL
tested	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
.	NULL

The	NULL
plasmid	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
contains	NULL
-71	NULL
to	NULL
+53	NULL
bp	NULL
of	NULL
somatostatin	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
and	NULL
this	NULL
plasmid	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
CREB	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Both	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induced	NULL
14.1	NULL
+	NULL
2.5-fold	NULL
and	NULL
13.4	NULL
+	NULL
2.1-fold	NULL
(	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

,	NULL
n	NULL
=	NULL
6	NULL
)	NULL
increase	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
transfected	NULL
macrophage	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

RAW264.7	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
showed	NULL
no	NULL
induced	NULL
CAT	NULL
activity	NULL
upon	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
induced	NULL
CAT	NULL
activity	NULL
in	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
ATF-1	NULL
and/or	NULL
CREB	NULL
,	NULL
we	NULL
co-transfected	NULL
RAW264.7	NULL
cells	NULL
with	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
and	NULL
A-ATFl	NULL
(	NULL
a	NULL
dominant	NULL
negative	NULL
inhibitor	NULL
of	NULL
ATF-1	NULL
)	NULL
,	NULL
A-CREB	NULL
(	NULL
a	NULL
dominant	NULL
negative	NULL
inhibitor	NULL
of	NULL
CREB	NULL
)	NULL
,	NULL
or	NULL
the	NULL
empty	NULL
CMV	NULL
.	NULL

These	NULL
dominant	NULL
negative	NULL
proteins	NULL
were	NULL
constructed	NULL
by	NULL
fusing	NULL
an	NULL
acidic	NULL
extension	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
.	NULL

This	NULL
acidic	NULL
region	NULL
of	NULL
the	NULL
recombinant	NULL
protein	NULL
binds	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
basic	NULL
region	NULL
is	NULL
thus	NULL
no	NULL
longer	NULL
available	NULL
for	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

Both	NULL
dominant	NULL
negative	NULL
ATF-1	NULL
and	NULL
dominant	NULL
negative	NULL
CREB	NULL
,	NULL
individually	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
inhibited	NULL
the	NULL
sPGN-	NULL
or	NULL
ReLPS-induced	NULL
activation	NULL
of	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
specific	NULL
for	NULL
A-ATFL	NULL
and	NULL
A-CREB	NULL
,	NULL
as	NULL
the	NULL
empty	NULL
vector	NULL
did	NULL
not	NULL
inhibit	NULL
sPGN-	NULL
or	NULL
ReLPS-	NULL
induced	NULL
CAT	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
that	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
ATF-1	NULL
and	NULL
CREB	NULL
.	NULL

sPGN	NULL
and	NULL
ReLPS	NULL
Induce	NULL
Phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
Protein	NULL
Synthesis	NULL
of	NULL
JunB	NULL
and	NULL
c-Fos-We	NULL
next	NULL
determined	NULL
if	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
family	NULL
consists	NULL
of	NULL
proteins	NULL
which	NULL
include	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Fos	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
14015	NULL
A	NULL
6000	NULL
B	NULL
100	NULL
80	NULL
5000	NULL
4000	NULL
60	NULL
3000	NULL
40	NULL
CAT	NULL
(	NULL
cpm	NULL
)	NULL
2000	NULL
20	NULL
1000	NULL
Percent	NULL
of	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
o	NULL
2s	NULL
Bah	NULL
~	NULL
)	NULL
+71	NULL
Som-CAT	NULL
pUC13	NULL
cmy	NULL
A-CREB	NULL
f	NULL
A-ATF1	NULL
+	NULL
A-CREB	NULL
Fic	NULL
.	NULL

3.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
transactivation	NULL
of	NULL
a	NULL
CREB-regulated	NULL
gene	NULL
,	NULL
and	NULL
this	NULL
induction	NULL
is	NULL
inhibited	NULL
by	NULL
dominant	NULL
negative	NULL
CREB	NULL
(	NULL
A-CREB	NULL
)	NULL
and	NULL
dominant	NULL
negative	NULL
ATF-1	NULL
(	NULL
A-ATF1	NULL
)	NULL
.	NULL

A	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1.0	NULL
ug/ml	NULL
CREB-regulated	NULL
CAT	NULL
plasmid	NULL
,	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
,	NULL
or	NULL
empty	NULL
vector	NULL
,	NULL
pUC18	NULL
;	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
for	NULL
86	NULL
h	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
means	NULL
of	NULL
duplicate	NULL
samples	NULL
from	NULL
one	NULL
out	NULL
of	NULL
six	NULL
similar	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
1.0	NULL
ug/ml	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
and	NULL
2.0	NULL
ug/ml	NULL
A-ATF1	NULL
,	NULL
or	NULL
A-CREB	NULL
,	NULL
or	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
,	NULL
or	NULL
2.0	NULL
ug/ml	NULL
each	NULL
of	NULL
A-ATF1	NULL
and	NULL
A-CREB	NULL
or	NULL
4.0	NULL
ug/ml	NULL
CMV	NULL
and	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
in	NULL
A	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
empty	NULL
vector	NULL
=	NULL
(	NULL
mean	NULL
cpm	NULL
stimulated	NULL
with	NULL
dominant	NULL
negative	NULL
-	NULL
mean	NULL
cpm	NULL
unstimulated	NULL
with	NULL
dominant	NULL
negative	NULL
)	NULL
X	NULL
100/	NULL
(	NULL
mean	NULL
cpm	NULL
stimulated	NULL
with	NULL
empty	NULL
vector	NULL
-	NULL
mean	NULL
cpm	NULL
unstimulated	NULL
with	NULL
empty	NULL
vector	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
three	NULL
experiments	NULL
.	NULL

binds	NULL
to	NULL
the	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
response	NULL
el-ement	NULL
,	NULL
usually	NULL
as	NULL
a	NULL
Jun-Fos	NULL
heterodimer	NULL
.	NULL

c-Jun	NULL
is	NULL
activated	NULL
by	NULL
phosphorylation	NULL
of	NULL
serine	NULL
63	NULL
and	NULL
serine	NULL
73	NULL
.	NULL

To	NULL
test	NULL
if	NULL
sPGN	NULL
activates	NULL
c-Jun	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
and	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
was	NULL
measured	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
phosphorylated	NULL
serine	NULL
63	NULL
and	NULL
the	NULL
adjacent	NULL
c-Jun	NULL
sequence	NULL
.	NULL

sPGN	NULL
consistently	NULL
induced	NULL
rapid	NULL
and	NULL
transient	NULL
dose-dependent	NULL
phosphorylation	NULL
and	NULL
hyperphosphorylation	NULL
of	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

ReLPS	NULL
induced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
sPGN	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Stripping	NULL
and	NULL
reprobing	NULL
the	NULL
blots	NULL
with	NULL
anti-c-Jun	NULL
antibody	NULL
,	NULL
which	NULL
recognizes	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
protein	NULL
,	NULL
revealed	NULL
that	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
stimulation	NULL
also	NULL
causes	NULL
a	NULL
modest	NULL
increase	NULL
(	NULL
1.5-2	NULL
times	NULL
)	NULL
in	NULL
the	NULL
total	NULL
(	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
amount	NULL
of	NULL
c-Jun	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
unexpected	NULL
as	NULL
activated	NULL
c-Jun	NULL
protein	NULL
induces	NULL
transcription	NULL
of	NULL
the	NULL
c-Jun	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

sPGN-induced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
polymyxin	NULL
B	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
phosphorylation	NULL
induced	NULL
by	NULL
ReLPS	NULL
,	NULL
which	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
polymyxin	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
that	NULL
sPGN-induced	NULL
activation	NULL
of	NULL
RAW264.7	NULL
cells	NULL
and	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
is	NULL
due	NULL
to	NULL
PGN	NULL
and	NULL
not	NULL
due	NULL
to	NULL
an	NULL
endotoxin	NULL
contaminant	NULL
in	NULL
our	NULL
sPGN	NULL
prepa-ration	NULL
.	NULL

In	NULL
control	NULL
experiments	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
c-Jun	NULL
protein	NULL
did	NULL
not	NULL
change	NULL
with	NULL
polymyxin	NULL
B	NULL
treatment	NULL
,	NULL
for	NULL
either	NULL
stimulant	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
anti-phosphorylated	NULL
c-Jun	NULL
antibody	NULL
recognizes	NULL
phosphorylated	NULL
c-Jun	NULL
,	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
phosphatases	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
both	NULL
sPGN-	NULL
and	NULL
ReLPS-stimulated	NULL
cells	NULL
,	NULL
treated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
,	NULL
a	NULL
nonspecific	NULL
phosphatase	NULL
,	NULL
did	NULL
not	NULL
show	NULL
any	NULL
binding	NULL
to	NULL
the	NULL
anti-phosphorylated	NULL
c-Jun	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
protein	NULL
phosphatase	NULL
2A	NULL
,	NULL
a	NULL
serine	NULL
phosphatase	NULL
,	NULL
strongly	NULL
diminished	NULL
binding	NULL
to	NULL
the	NULL
anti-phosphorylated	NULL
c-Jun	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
anti-c-Jun	NULL
antibody	NULL
was	NULL
not	NULL
eliminated	NULL
or	NULL
reduced	NULL
by	NULL
either	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
14016	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
A	NULL
anti-pcJun	NULL
Blot	NULL
B	NULL
anti-cJun	NULL
Blot	NULL
sPGN	NULL
ReLPS	NULL
sPGN	NULL
ReLPS	NULL
o	NULL
o	NULL
o	NULL
o	NULL
0	NULL
o	NULL
0	NULL
o	NULL
Min	NULL
o	NULL
2838	NULL
%	NULL
0	NULL
``	NULL
88	NULL
``	NULL
&	NULL
Min	NULL
0238830288	NULL
``	NULL
§	NULL
56	NULL
-	NULL
56	NULL
ias	NULL
an	NULL
m	NULL
«	NULL
-	NULL
‘	NULL
.	NULL

--	NULL
tPCJun	NULL
e	NULL
--	NULL
..	NULL
--	NULL
--	NULL
;	NULL
.	NULL

--	NULL
|	NULL
tcdun	NULL
34	NULL
-	NULL
34	NULL
anti-pcJun	NULL
Blot	NULL
G	NULL
sPGN	NULL
_	NULL
ReLPS	NULL
z	NULL
P	NULL
ug/ml	NULL
ng/ml	NULL
G	NULL
a	NULL
Z	NULL
o	NULL
4	NULL
£	NULL
#	NULL
s	NULL
``	NULL
on	NULL
8508	NULL
=	NULL
--	NULL
o	NULL
sca	NULL
e	NULL
8666	NULL
-r	NULL
Polymyxin	NULL
B	NULL
--	NULL
+-++	NULL
56	NULL
43	NULL
--	NULL
#	NULL
%	NULL
&	NULL
nil	NULL
le	NULL
<	NULL
4	NULL
peJun	NULL
I	NULL
34	NULL
-	NULL
o	NULL
;	NULL
—	NULL
e	NULL
o	NULL
.	NULL

0	NULL
p.	NULL
anti-cJun	NULL
Blot	NULL
g	NULL
sPGN	NULL
ReLPS	NULL
28	NULL
D	NULL
z	NULL
@	NULL
§	NULL
ug/ml	NULL
ng/ml	NULL
0	NULL
i	NULL
Fel	NULL
a	NULL
o	NULL
o	NULL
%	NULL
£	NULL
g	NULL
&	NULL
o	NULL
r	NULL
o	NULL
lone	NULL
thas	NULL
1°	NULL
4	NULL
%	NULL
06	NULL
0	NULL
R	NULL
s	NULL
o	NULL
6	NULL
ra	NULL
«	NULL
-a	NULL
66	NULL
+-	NULL
Polymyxin	NULL
B	NULL
--	NULL
+-++	NULL
E	NULL
’	NULL
56	NULL
-	NULL
g	NULL
dd	NULL
.	NULL

43	NULL
-	NULL
f	NULL
AAA	NULL
4	NULL
h	NULL
i	NULL
an	NULL
a	NULL
h	NULL
k	NULL
AAABk	NULL
ae	NULL
<	NULL
oun	NULL
§	NULL
34	NULL
-	NULL
g	NULL
<	NULL
&	NULL
s	NULL
©	NULL
anti-pcJun	NULL
Blot	NULL
anti-cJun	NULL
Blot	NULL
3	NULL
2	NULL
\o	NULL
E	NULL
a	NULL
ca	NULL
F	NULL
z	NULL
®	NULL
f	NULL
o	NULL
g	NULL
S	NULL
Gf	NULL
o	NULL
G	NULL
tC	NULL
Lol	NULL
w	NULL
[	NULL
cd	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
Enzyme	NULL
.	NULL

%	NULL
&	NULL
.	NULL

%	NULL
&	NULL
.	NULL

%	NULL
&	NULL
Enzyme	NULL
.	NULL

%	NULL
&	NULL
.	NULL

%	NULL
&	NULL
.	NULL

&	NULL
&	NULL
56	NULL
-	NULL
56	NULL
48	NULL
~	NULL
aas	NULL
aam	NULL
4	NULL
peJun	NULL
43_	NULL
--	NULL
--	NULL
wn	NULL
em	NULL
=	NULL
<	NULL
-	NULL
cJun	NULL
34	NULL
-	NULL
34	NULL
Fig	NULL
.	NULL

4.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
:	NULL
time	NULL
kinetics	NULL
,	NULL
dose	NULL
response	NULL
,	NULL
effect	NULL
of	NULL
polymyxin	NULL
B	NULL
,	NULL
and	NULL
elimination	NULL
by	NULL
phosphatase	NULL
.	NULL

RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
total	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blots	NULL
for	NULL
:	NULL
phosphorylated	NULL
c-Jun	NULL
(	NULL
A	NULL
)	NULL
or	NULL
total	NULL
(	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
c-Jun	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
phosphorylated	NULL
c-Jun	NULL
(	NULL
C	NULL
)	NULL
or	NULL
total	NULL
c-Jun	NULL
protein	NULL
(	NULL
D	NULL
)	NULL
.	NULL

£	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
in	NULL
A	NULL
for	NULL
30	NULL
min	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
treated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
AP	NULL
)	NULL
or	NULL
protein	NULL
phosphatase	NULL
2A	NULL
(	NULL
PP2A	NULL
)	NULL
or	NULL
not	NULL
treated	NULL
with	NULL
any	NULL
enzyme	NULL
and	NULL
analyzed	NULL
for	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
by	NULL
Western	NULL
blots	NULL
.	NULL

F	NULL
,	NULL
the	NULL
blot	NULL
shown	NULL
in	NULL
E	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-c-Jun	NULL
Ab	NULL
.	NULL

The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

phosphatase	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4F	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
-	NULL
synthesis	NULL
in	NULL
RAW264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

ReLPS	NULL
also	NULL
induced	NULL
in-the	NULL
anti-phosphorylated	NULL
c-Jun	NULL
antibody	NULL
was	NULL
indeed	NULL
specific	NULL
for	NULL
-	NULL
creases	NULL
in	NULL
JunB	NULL
and	NULL
c-Fos	NULL
proteins	NULL
,	NULL
but	NULL
not	NULL
of	NULL
JunD	NULL
protein	NULL
the	NULL
phosphorylated	NULL
c-Jun	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
up-regulation	NULL
of	NULL
JunB	NULL
by	NULL
sPGN	NULL
was	NULL
not	NULL
inhibited	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Fos	NULL
are	NULL
other	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
_	NULL
by	NULL
polymyxin	NULL
B	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
ReLPS-induced	NULL
increase	NULL
in	NULL
JunB	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

sPGN	NULL
consistently	NULL
induced	NULL
a	NULL
dose-de-	NULL
-	NULL
protein	NULL
,	NULL
which	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
polymyxin	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

pendent	NULL
increase	NULL
of	NULL
JunB	NULL
and	NULL
c-Fos	NULL
,	NULL
but	NULL
not	NULL
of	NULL
JunD	NULL
protein	NULL
-	NULL
5B	NULL
)	NULL
.	NULL

Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
A	NULL
anti-JunB	NULL
Blot	NULL
sPGN	NULL
ReLPS	NULL
o	NULL
o	NULL
c	NULL
o	NULL
Min	NULL
o	NULL
8028878	NULL
so	NULL
se	NULL
-	NULL
``	NULL
43	NULL
-	NULL
=	NULL
@	NULL
@	NULL
+	NULL
.m	NULL
pig	NULL
maz	NULL
-	NULL
$	NULL
-	NULL
JunB	NULL
34	NULL
B	NULL
anti-JunB	NULL
Blot	NULL
sPGN	NULL
ReLPS	NULL
w	NULL
Z	NULL
o.	NULL
ug/ml	NULL
ng/m	NULL
!	NULL

0	NULL
J	NULL
-__	NULL
_-	NULL
a	NULL
.	NULL

@	NULL
+-	NULL
0	NULL
a	NULL
a	NULL
or	NULL
§	NULL
$	NULL
s	NULL
.	NULL

2°	NULL
``	NULL
0a	NULL
22196	NULL
o	NULL
6	NULL
/n	NULL
rea	NULL
~~	NULL
Polymyxin	NULL
B	NULL
--	NULL
+-++	NULL
#	NULL
0	NULL
56	NULL
-n-	NULL
~	NULL
``	NULL
*s2s	NULL
``	NULL
iff	NULL
qoujune	NULL
34	NULL
C	NULL
anti-JunD	NULL
Blot	NULL
D	NULL
anti-cFos	NULL
Blot	NULL
sPGN	NULL
ReLPS	NULL
sPGN	NULL
ReLPS	NULL
o	NULL
o	NULL
c	NULL
o	NULL
o	NULL
o	NULL
PCI	NULL
Min	NULL
,	NULL
28	NULL
$	NULL
8	NULL
&	NULL
Min	NULL
60	NULL
-	NULL
132	NULL
a	NULL
on	NULL
an	NULL
n	NULL
4a	NULL
&	NULL
an	NULL
tn	NULL
t	NULL
an	NULL
om	NULL
an	NULL
an	NULL
gp	NULL
dh	NULL
an	NULL
th	NULL
t	NULL
ap	NULL
ass	NULL
(	NULL
D	NULL
90	NULL
56	NULL
w	NULL
om	NULL
on	NULL
an	NULL
am	NULL
db	NULL
an	NULL
ah	NULL
in	NULL
gs	NULL
ia	NULL
th	NULL
x	NULL
«	NULL
43	NULL
-	NULL
56	NULL
-	NULL
ke	NULL
«	NULL
-=	NULL
4-	NULL
c-Fos	NULL
sss	NULL
<	NULL
-JunD	NULL
34	NULL
Fic	NULL
.	NULL

5.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
synthesis	NULL
of	NULL
JunB	NULL
and	NULL
c-Fos	NULL
proteins	NULL
.	NULL

RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
for	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
or	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
for	NULL
B	NULL
and	NULL
analyzed	NULL
for	NULL
total	NULL
protein	NULL
using	NULL
an	NULL
anti-JunB	NULL
Ab	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
anti-JunD	NULL
Ab	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
anti-cFos	NULL
Ab	NULL
(	NULL
D	NULL
)	NULL
.	NULL

JunB	NULL
runs	NULL
as	NULL
a	NULL
doublet	NULL
as	NULL
shown	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Fos	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
;	NULL
all	NULL
other	NULL
bands	NULL
are	NULL
nonspecific	NULL
.	NULL

The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
c-Fos	NULL
Bind	NULL
to	NULL
the	NULL
TPA-RE	NULL
Consensus	NULL
Sequence	NULL
in	NULL
sPGN-stimulated	NULL
Cells-To	NULL
identify	NULL
the	NULL
specific	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
TPA-RE	NULL
consensus	NULL
sequence	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
per-formed	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
an	NULL
oligonucleotide	NULL
with	NULL
the	NULL
TPA-RE	NULL
sequence	NULL
showed	NULL
no	NULL
differences	NULL
between	NULL
sPGN-	NULL
or	NULL
ReLPS-stimulated	NULL
and	NULL
unstimulated	NULL
RAW264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
;	NULL
gel	NULL
shift	NULL
assays	NULL
with	NULL
unstimulated	NULL
lysates	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
supershift	NULL
assay	NULL
and	NULL
a	NULL
series	NULL
of	NULL
antibodies	NULL
that	NULL
recognize	NULL
different	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
CREB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
in	NULL
both	NULL
sPGN-	NULL
and	NULL
ReLPS-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
and	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
c-Fos	NULL
bind	NULL
to	NULL
the	NULL
TPA-RE	NULL
sequence	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
oligonucleotide	NULL
that	NULL
was	NULL
used	NULL
in	NULL
the	NULL
supershift	NULL
assays	NULL
was	NULL
confirmed	NULL
by	NULL
inhibition	NULL
of	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
oligonucleo-tide	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
with	NULL
no	NULL
TPA-RE	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

sPGN	NULL
Induces	NULL
Transactivation	NULL
of	NULL
an	NULL
AP-I-regulated	NULL
Gene	NULL
That	NULL
Is	NULL
Inhibited	NULL
by	NULL
Dominant	NULL
Negative	NULL
c-Fos-To	NULL
determine	NULL
if	NULL
sPGN	NULL
induced	NULL
functional	NULL
activation	NULL
of	NULL
AP-1	NULL
,	NULL
we	NULL
transfected	NULL
RAW264.7	NULL
cells	NULL
with	NULL
the	NULL
plasmid	NULL
pAP1-Luce	NULL
,	NULL
which	NULL
has	NULL
seven	NULL
AP-1	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
or	NULL
-60Col-Luc	NULL
,	NULL
which	NULL
has	NULL
no	NULL
AP-1	NULL
binding	NULL
sites	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
pAP1-Luc	NULL
showed	NULL
an	NULL
average	NULL
9.0	NULL
+	NULL
0.6-fold	NULL
and	NULL
9.4	NULL
+	NULL
1.4-fold	NULL
(	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
increase	NULL
in	NULL
inducible	NULL
luciferase	NULL
activity	NULL
when	NULL
stimulated	NULL
by	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
-60Col-Lue	NULL
showed	NULL
A	NULL
sPGN	NULL
ReLPS	NULL
ﬂm—ﬂ	NULL
a	NULL
2	NULL
c	NULL
ﬂm—ﬁ	NULL
w	NULL
n	NULL
:	NULL
<	NULL
ual	NULL
ul	NULL
Ego	NULL
“	NULL
ﬁzu	NULL
<	NULL
wd	NULL
d	NULL
53nd	NULL
«	NULL
at	NULL
,	NULL
Antibody	NULL
$	NULL
§4G4	NULL
15	NULL
218	NULL
$	NULL
544	NULL
iits	NULL
$	NULL
i	NULL
»	NULL
®	NULL
dub	NULL
bat	NULL
tub	NULL
d	NULL
Io	NULL
tat	NULL
we	NULL
-	NULL
WP	NULL
W	NULL
tu	NULL
but	NULL
ba	NULL
but	NULL
tak	NULL
44	NULL
W	NULL
#	NULL
#	NULL
B	NULL
sPGN	NULL
ReLPS	NULL
Competitor	NULL
TPA-RE	NULL
NS	NULL
TPA-RE	NULL
NS	NULL
o	NULL
o	NULL
o	NULL
o	NULL
Fold	NULL
Excess	NULL
eR§R§	NULL
@	NULL
Z	NULL
indubial	NULL
Lidhdhal	NULL
Fic	NULL
.	NULL

6.	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
c-Fos	NULL
bind	NULL
to	NULL
the	NULL
TPA-RE	NULL
consensus	NULL
sequence	NULL
in	NULL
sPGN-	NULL
and	NULL
ReLPS-stimulated	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
with	NULL
a	NULL
radioactively	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
TPA-RE	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
nondenaturing	NULL
polyacry	NULL
]	NULL
-amide	NULL
gel	NULL
.	NULL

The	NULL
band	NULL
was	NULL
shifted	NULL
by	NULL
JunB	NULL
and	NULL
c-Fos	NULL
Abs	NULL
and	NULL
eliminated	NULL
with	NULL
c-Jun	NULL
Abs	NULL
.	NULL

B	NULL
,	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
TPA-RE	NULL
site	NULL
was	NULL
demonstrated	NULL
using	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
(	NULL
TPA-RE	NULL
)	NULL
and	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
oligonucleotides	NULL
.	NULL

The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

A	NULL
Light	NULL
output	NULL
%	NULL
of	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
pAP1-Lue	NULL
-	NULL
-60	NULL
Col-Lue	NULL
Fic	NULL
.	NULL

7.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
transactivation	NULL
of	NULL
an	NULL
AP-1-regulated	NULL
gene	NULL
,	NULL
and	NULL
this	NULL
induction	NULL
is	NULL
inhibited	NULL
by	NULL
dominant	NULL
negative	NULL
c-Fos	NULL
.	NULL

A	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.5	NULL
ug/ml	NULL
pAP1-Lue	NULL
plasmid	NULL
or	NULL
the	NULL
empty	NULL
vector	NULL
-60Col-Lue	NULL
;	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
for	NULL
5	NULL
h	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
means	NULL
of	NULL
duplicate	NULL
samples	NULL
from	NULL
one	NULL
out	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
RAW264.7	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
0.5	NULL
ug/ml	NULL
pAP1-Lue	NULL
plasmid	NULL
and	NULL
1.0	NULL
ug/ml	NULL
dominant	NULL
negative	NULL
A-Fos	NULL
,	NULL
or	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
in	NULL
A	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
control	NULL
vector	NULL
was	NULL
calculated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
results	NULL
are	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
three	NULL
experiments	NULL
.	NULL

no	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
stimulants	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

We	NULL
also	NULL
confirmed	NULL
activation	NULL
of	NULL
AP-1	NULL
by	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
using	NULL
two	NULL
additional	NULL
plasmids	NULL
:	NULL
-783Col-Lue	NULL
,	NULL
which	NULL
has	NULL
-73	NULL
to	NULL
+63	NULL
bp	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
and	NULL
2xAP1-Luc	NULL
,	NULL
which	NULL
has	NULL
two	NULL
AP-1	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induced	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
14018	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
A	NULL
anti-pCREB	NULL
Blot	NULL
B	NULL
anti-CREB	NULL
Blot	NULL
sPGN	NULL
ReLPS	NULL
sPGN	NULL
ReLPS	NULL
-	NULL
]	NULL
0	NULL
o	NULL
o	NULL
MinamBSS-	NULL
‘	NULL
fomfggﬁ	NULL
Min	NULL
amgggﬁamﬁgsﬁ	NULL
90-	NULL
90-56-	NULL
56-	NULL
te	NULL
a	NULL
&	NULL
a	NULL
a	NULL
a	NULL
m	NULL
a	NULL
-	NULL
<	NULL
-	NULL
pCREB	NULL
a	NULL
a	NULL
a	NULL
aaa	NULL
a	NULL
ads	NULL
ao	NULL
<	NULL
-	NULL
CREB	NULL
Fic	NULL
.	NULL

8.	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
c-Jun	NULL
in	NULL
human	NULL
C	NULL
THP-1	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
phosphorylation	NULL
is	NULL
anti-pcJun	NULL
Blot	NULL
a3-	NULL
anti-cJun	NULL
Blot	NULL
inhibited	NULL
by	NULL
anti-CD14	NULL
antibodies	NULL
.	NULL

THP-1	NULL
sPGN	NULL
ReLPS	NULL
sPGN	NULL
ReLPS	NULL
cells	NULL
were	NULL
differentiated	NULL
with	NULL
100	NULL
nM	NULL
vitamin	NULL
o	NULL
[	NULL
ferments	NULL
D3	NULL
for	NULL
72	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
10	NULL
ug/ml	NULL
Min	NULL
w	NULL
o	NULL
o	NULL
a	NULL
w	NULL
o	NULL
o	NULL
a	NULL
Min	NULL
n	NULL
o	NULL
o	NULL
a	NULL
n	NULL
o	NULL
o	NULL
a	NULL
sPGN	NULL
or	NULL
10	NULL
ng/ml	NULL
ReLPS	NULL
(	NULL
A-F	NULL
``	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
fam	NULL
i	NULL
times	NULL
(	NULL
A-D	NULL
)	NULL
.	NULL

In	NULL
E	NULL
and	NULL
F	NULL
,	NULL
differentiated	NULL
cells	NULL
=	NULL
-	NULL
-	NULL
;	NULL
:	NULL
-—	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
10	NULL
pg/ml	NULL
56	NULL
-	NULL
56	NULL
anti-CD14	NULL
antibodies	NULL
,	NULL
MY4	NULL
or	NULL
MEM18	NULL
,	NULL
or	NULL
con-	NULL
«	NULL
«	NULL
ae	NULL
«	NULL
«	NULL
«	NULL
seme	NULL
4	NULL
trol	NULL
IgG	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cell	NULL
43	NULL
-	NULL
R	NULL
pe	NULL
43	NULL
-	NULL
a	NULL
»	NULL
lysates	NULL
were	NULL
analyzed	NULL
with	NULL
antibodies	NULL
to	NULL
:	NULL
phos-	NULL
|	NULL
£3	NULL
*Bé	NULL
4	NULL
posun	NULL
=	NULL
'	NULL
i	NULL
-	NULL
&	NULL
'	NULL
.	NULL

4	NULL
oJun	NULL
phorylated	NULL
CREB	NULL
(	NULL
A	NULL
and	NULL
£	NULL
)	NULL
,	NULL
total	NULL
(	NULL
phosphoryl-	NULL
38	NULL
8a	NULL
ated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
CREB	NULL
(	NULL
B	NULL
)	NULL
,	NULL
phos-	NULL
``	NULL
&	NULL
phorylated	NULL
c-Jun	NULL
(	NULL
C	NULL
and	NULL
F	NULL
)	NULL
and	NULL
total	NULL
(	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
)	NULL
c-Jun	NULL
(	NULL
D	NULL
)	NULL
.	NULL

pCREB	NULL
,	NULL
pc-Jun	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
c-Jun	NULL
are	NULL
indi-	NULL
.	NULL

R	NULL
cated	NULL
by	NULL
arrows	NULL
;	NULL
all	NULL
other	NULL
bands	NULL
are	NULL
nonspecific	NULL
.	NULL

E	NULL
anti-pCREB	NULL
Blot	NULL
F	NULL
anti-pcJun	NULL
Blot	NULL
The	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
similar	NULL
iw	NULL
experiments	NULL
.	NULL

g	NULL
5	NULL
g	NULL
n	NULL
o	NULL
~	NULL
E	NULL
o	NULL
&	NULL
3	NULL
c	NULL
&	NULL
©	NULL
&	NULL
LJ	NULL
c	NULL
to	NULL
<	NULL
=	NULL
=	NULL
Cal-	NULL
a	NULL
=	NULL
a	NULL
=	NULL
a	NULL
=	NULL
0	NULL
&	NULL
0	NULL
0	NULL
0	NULL
G	NULL
Antibodvlggs	NULL
‘	NULL
29.529	NULL
AntibodV|E§9|E§9|E§9	NULL
90	NULL
56	NULL
56	NULL
a	NULL
a	NULL
=	NULL
»	NULL
<	NULL
-	NULL
pCREB	NULL
43	NULL
~-43	NULL
-	NULL
#	NULL
``	NULL
EET	NULL
°OZ2	NULL
Eposun	NULL
34	NULL
34	NULL
To	NULL
confirm	NULL
that	NULL
the	NULL
sPGN-	NULL
or	NULL
ReLPS-induced	NULL
luciferase	NULL
activity	NULL
was	NULL
due	NULL
to	NULL
AP-1	NULL
,	NULL
we	NULL
co-transfected	NULL
RAW264.7	NULL
cells	NULL
with	NULL
pAP1-Luc	NULL
and	NULL
A-Fos	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
c-Fos	NULL
,	NULL
or	NULL
empty	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
.	NULL

A-Fos	NULL
heterodimerizes	NULL
with	NULL
Jun	NULL
proteins	NULL
in	NULL
an	NULL
AP-1	NULL
complex	NULL
and	NULL
inactivates	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

A-Fos	NULL
,	NULL
but	NULL
not	NULL
the	NULL
empty	NULL
vector	NULL
,	NULL
inhibited	NULL
both	NULL
sPGN-	NULL
and	NULL
ReLPS-induced	NULL
increases	NULL
in	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
induce	NULL
a	NULL
functionally	NULL
active	NULL
AP-1	NULL
,	NULL
and	NULL
that	NULL
c-Fos	NULL
and	NULL
Jun	NULL
form	NULL
the	NULL
active	NULL
AP-1	NULL
complex	NULL
.	NULL

sPGN-induced	NULL
Phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
c-Jun	NULL
in	NULL
Human	NULL
Monocytes	NULL
Is	NULL
CD14-dependent-Since	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
sPGN-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
membrane	NULL
receptor	NULL
CD14	NULL
(	NULL
8	NULL
)	NULL
,	NULL
we	NULL
now	NULL
determined	NULL
if	NULL
sPGN-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
c-Jun	NULL
also	NULL
requires	NULL
CD14	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
if	NULL
sPGN	NULL
induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
c-Jun	NULL
in	NULL
the	NULL
human	NULL
monocyte	NULL
cell	NULL
line	NULL
THP-1	NULL
.	NULL

THP-1	NULL
cells	NULL
activated	NULL
with	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
showed	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

THP	NULL
-1	NULL
cells	NULL
differed	NULL
from	NULL
the	NULL
mouse	NULL
RAW264.7	NULL
cells	NULL
,	NULL
in	NULL
that	NULL
they	NULL
did	NULL
not	NULL
have	NULL
detectable	NULL
levels	NULL
of	NULL
ATF-1	NULL
,	NULL
which	NULL
in	NULL
RAW264.7	NULL
cells	NULL
was	NULL
present	NULL
in	NULL
high	NULL
amounts	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
and	NULL
was	NULL
strongly	NULL
phosphorylated	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Total	NULL
amount	NULL
of	NULL
CREB	NULL
did	NULL
not	NULL
change	NULL
upon	NULL
cell	NULL
activation	NULL
by	NULL
sPGN	NULL
or	NULL
ReLPS	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

sPGN	NULL
or	NULL
ReLPS	NULL
also	NULL
induced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
in	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
c-Jun	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
c-Jun	NULL
protein	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
activated	NULL
c-Jun	NULL
itself	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
transcription	NULL
of	NULL
the	NULL
c-Jun	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Anti-CD14	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
MY4	NULL
and	NULL
MEM18	NULL
,	NULL
inhibited	NULL
both	NULL
sPGN-	NULL
and	NULL
ReLPS-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

8E	NULL
)	NULL
and	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

8F	NULL
)	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
that	NULL
sPGN	NULL
and	NULL
ReLPS	NULL
activate	NULL
cells	NULL
through	NULL
CD14	NULL
and	NULL
that	NULL
CD14	NULL
is	NULL
required	NULL
for	NULL
both	NULL
sPGN-	NULL
and	NULL
ReLPS-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
c-Jun	NULL
.	NULL

Lysostaphin	NULL
and	NULL
Lysozyme	NULL
Reduce	NULL
sPGN-induced	NULL
Phosphorylation	NULL
of	NULL
ATF-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
c-Jun-To	NULL
confirm	NULL
the	NULL
identity	NULL
of	NULL
sPGN	NULL
as	NULL
the	NULL
activating	NULL
molecule	NULL
that	NULL
induces	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
c-Jun	NULL
,	NULL
sPGN	NULL
was	NULL
digested	NULL
with	NULL
lysostaphin	NULL
or	NULL
lysozyme	NULL
,	NULL
enzymes	NULL
that	NULL
specifically	NULL
degrade	NULL
PGN	NULL
.	NULL

Digestion	NULL
with	NULL
both	NULL
enzymes	NULL
reduced	NULL
sPGN-induced	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
and	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
,	NULL
and	NULL
this	NULL
reduction	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
extent	NULL
of	NULL
digestion	NULL
of	NULL
sPGN	NULL
(	NULL
Fig	NULL
.	NULL

96	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
and	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

9D	NULL
)	NULL
proteins	NULL
remained	NULL
the	NULL
same	NULL
in	NULL
all	NULL
treated	NULL
and	NULL
untreated	NULL
groups	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
results	NULL
demonstrate	NULL
that	NULL
:	NULL
(	NULL
i	NULL
)	NULL
PGN	NULL
induces	NULL
phosphorylation	NULL
and	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
A	NULL
-	NULL
anti-pCREB	NULL
and	NULL
B	NULL
-	NULL
anti-cREB	NULL
Biot	NULL
anti-pATF-1	NULL
Blot	NULL
z	NULL
Z	NULL
g	NULL
G	NULL
0	NULL
a	NULL
0	NULL
%	NULL
8	NULL
w	NULL
o	NULL
m	NULL
&	NULL
N	NULL
&	NULL
m	NULL
Enzyme	NULL
1	NULL
13323	NULL
Enzyme	NULL
i	NULL
(	NULL
33323	NULL
90-56-	NULL
aa	NULL
aa	NULL
ae	NULL
ad	NULL
as	NULL
43-	NULL
®	NULL
+4	NULL
<	NULL
-	NULL
pCREB	NULL
*a	NULL
ea	NULL
ee	NULL
<	NULL
-	NULL
CREB	NULL
@	NULL
-+	NULL
<	NULL
-	NULL
pATF-1	NULL
34-C	NULL
_	NULL
anti-peJun	NULL
Blot	NULL
D	NULL
-	NULL
anti-egun	NULL
Blot	NULL
s	NULL
3	NULL
o	NULL
%	NULL
o	NULL
%	NULL
&	NULL
N	NULL
G	NULL
N	NULL
o	NULL
w	NULL
a	NULL
m	NULL
Enzyme	NULL
;	NULL
,	NULL
2222	NULL
Enzyme	NULL
,	NULL
,	NULL
3322	NULL
90-56-	NULL
<	NULL
-	NULL
pedun	NULL
@	NULL
®	NULL
*	NULL
a	NULL
e	NULL
0	NULL
<	NULL
-	NULL
cJun	NULL
34	NULL
spon	NULL
rrr	NULL
sPGN	NULL
+	NULL
Lysostaphin	NULL
222	NULL
)	NULL
sPGN	NULL
+	NULL
Lysozyme	NULL
LH	NULL
o	NULL
Bs	NULL
soo	NULL
fs	NULL
doo	NULL
12s	NULL
14C-Ala	NULL
in	NULL
sPGN	NULL
(	NULL
cpm	NULL
)	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Lysostaphin	NULL
and	NULL
lysozyme	NULL
treatments	NULL
reduce	NULL
the	NULL
capacity	NULL
of	NULL
sPGN	NULL
to	NULL
induce	NULL
phosphorylation	NULL
of	NULL
ATF-L/CREB	NULL
and	NULL
c-Jun	NULL
.	NULL

[	NULL
'*C	NULL
]	NULL
Ala-labeled	NULL
sPGN	NULL
was	NULL
digested	NULL
with	NULL
1	NULL
mg/ml	NULL
lysostaphin	NULL
or	NULL
lysozyme	NULL
for	NULL
72	NULL
h	NULL
or	NULL
left	NULL
undigested	NULL
,	NULL
and	NULL
then	NULL
dialyzed	NULL
against	NULL
Dulbecco	NULL
's	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Aliquots	NULL
of	NULL
dialyzed	NULL
sPGN	NULL
were	NULL
used	NULL
to	NULL
stimulate	NULL
RAW264.7	NULL
cells	NULL
(	NULL
A-D	NULL
)	NULL
at	NULL
2	NULL
pg/ml	NULL
or	NULL
to	NULL
measure	NULL
the	NULL
remaining	NULL
'*C	NULL
in	NULL
nondialyzable	NULL
(	NULL
undigested	NULL
macromolecular	NULL
)	NULL
sPGN	NULL
(	NULL
£	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
with	NULL
antibodies	NULL
to	NULL
:	NULL
phosphorylated	NULL
CREB	NULL
(	NULL
A	NULL
)	NULL
,	NULL
total	NULL
CREB	NULL
(	NULL
B	NULL
)	NULL
,	NULL
phosphorylated	NULL
c-Jun	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
total	NULL
c-Jun	NULL
(	NULL
D	NULL
)	NULL
.	NULL

ATF-1	NULL
and	NULL
CREB	NULL
and	NULL
these	NULL
proteins	NULL
bind	NULL
DNA	NULL
as	NULL
a	NULL
dimer	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
PGN	NULL
induces	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
,	NULL
protein	NULL
synthesis	NULL
of	NULL
JunB	NULL
and	NULL
c-Fos	NULL
,	NULL
and	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
PGN-induced	NULL
activation	NULL
of	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
is	NULL
mediated	NULL
through	NULL
CD14	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
study	NULL
to	NULL
demonstrate	NULL
activation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
by	NULL
PGN	NULL
or	NULL
by	NULL
any	NULL
other	NULL
component	NULL
of	NULL
Gram-positive	NULL
bacteria	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
confirm	NULL
that	NULL
:	NULL
(	NULL
i	NULL
)	NULL
CREB	NULL
and	NULL
ATF-1	NULL
from	NULL
LPS-activated	NULL
nuclear	NULL
extracts	NULL
bind	NULL
the	NULL
CRE	NULL
sequence	NULL
(	NULL
28	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
LPS	NULL
induces	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
28	NULL
)	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
LPS	NULL
induces	NULL
increase	NULL
in	NULL
JunB	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
JunD	NULL
(	NULL
29	NULL
)	NULL
;	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
JunB	NULL
and	NULL
c-Jun	NULL
bind	NULL
the	NULL
TPA-RE	NULL
sequence	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
:	NULL
(	NULL
i	NULL
)	NULL
that	NULL
LPS	NULL
induces	NULL
phosphorylation	NULL
of	NULL
ATF-1	NULL
and	NULL
c-Jun	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
LPS-induced	NULL
activation	NULL
of	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
is	NULL
CD14-dependent	NULL
,	NULL
which	NULL
are	NULL
new	NULL
findings	NULL
for	NULL
LPS	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
demonstrate	NULL
that	NULL
LPS	NULL
induces	NULL
transcriptional	NULL
activation	NULL
:	NULL
(	NULL
i	NULL
)	NULL
of	NULL
a	NULL
CRE	NULL
reporter	NULL
plasmid	NULL
and	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
of	NULL
an	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
and	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
containing	NULL
c-Fos	NULL
proteins	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
other	NULL
investigators	NULL
'	NULL
results	NULL
showing	NULL
that	NULL
the	NULL
CRE	NULL
sites	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
TNF-a	NULL
(	NULL
30	NULL
)	NULL
,	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
P-selectin	NULL
(	NULL
82	NULL
)	NULL
genes	NULL
are	NULL
necessary	NULL
for	NULL
LPS-induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Also	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
findings	NULL
are	NULL
the	NULL
results	NULL
showing	NULL
that	NULL
site-specific	NULL
mutations	NULL
in	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
IL-1B	NULL
promoter	NULL
result	NULL
in	NULL
a	NULL
substantial	NULL
loss	NULL
in	NULL
transcriptional	NULL
induction	NULL
following	NULL
combined	NULL
stimulation	NULL
with	NULL
LPS	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
,	NULL
and	NULL
dibutyryl	NULL
cAMP	NULL
(	NULL
83	NULL
)	NULL
,	NULL
and	NULL
also	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
is	NULL
required	NULL
for	NULL
LPS-induced	NULL
transcrip-	NULL
14019	NULL
tional	NULL
activation	NULL
of	NULL
tissue	NULL
factor	NULL
(	NULL
34	NULL
)	NULL
and	NULL
heme	NULL
oxygenase	NULL
(	NULL
85	NULL
)	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
actual	NULL
protein	NULL
complex	NULL
that	NULL
binds	NULL
the	NULL
CRE	NULL
or	NULL
AP-1	NULL
site	NULL
and	NULL
regulates	NULL
transcription	NULL
may	NULL
be	NULL
different	NULL
for	NULL
different	NULL
genes	NULL
,	NULL
e.g	NULL
.	NULL

the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
IL-1B	NULL
promoter	NULL
binds	NULL
CREB	NULL
and	NULL
ATF-1	NULL
(	NULL
33	NULL
)	NULL
,	NULL
while	NULL
the	NULL
c-Jun	NULL
protein	NULL
binds	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
c-Jun	NULL
bound	NULL
to	NULL
this	NULL
site	NULL
increases	NULL
when	NULL
cells	NULL
are	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
different	NULL
proteins	NULL
may	NULL
have	NULL
different	NULL
effects	NULL
on	NULL
transcription	NULL
,	NULL
e.g	NULL
.	NULL

c-Jun	NULL
is	NULL
an	NULL
effective	NULL
transcriptional	NULL
acti-vator	NULL
,	NULL
while	NULL
JunB	NULL
is	NULL
not	NULL
,	NULL
and	NULL
thus	NULL
JunB	NULL
may	NULL
have	NULL
an	NULL
inhibi-tory	NULL
function	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
data	NULL
emphasize	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
CRE	NULL
and	NULL
AP-1	NULL
sites	NULL
and	NULL
the	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
LPS-induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
pro-inflammatory	NULL
genes	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
and	NULL
their	NULL
binding	NULL
sites	NULL
may	NULL
also	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
PGN-induced	NULL
inflammatory	NULL
response	NULL
.	NULL

Although	NULL
both	NULL
PGN	NULL
(	NULL
10	NULL
)	NULL
and	NULL
LPS	NULL
(	NULL
36	NULL
)	NULL
bind	NULL
to	NULL
CD14	NULL
and	NULL
activate	NULL
cells	NULL
through	NULL
CD14	NULL
(	NULL
8	NULL
)	NULL
,	NULL
there	NULL
are	NULL
several	NULL
differences	NULL
in	NULL
the	NULL
function	NULL
of	NULL
CD14	NULL
as	NULL
the	NULL
PGN	NULL
and	NULL
LPS	NULL
receptor	NULL
.	NULL

In	NULL
partic-ular	NULL
,	NULL
both	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
PGN	NULL
and	NULL
LPS	NULL
on	NULL
CD14	NULL
and	NULL
the	NULL
sites	NULL
needed	NULL
for	NULL
cell	NULL
activation	NULL
are	NULL
partially	NULL
similar	NULL
but	NULL
partially	NULL
different	NULL
(	NULL
8	NULL
,	NULL
10	NULL
)	NULL
,	NULL
and	NULL
only	NULL
LPS-induced	NULL
,	NULL
but	NULL
not	NULL
PGN-induced	NULL
cell	NULL
activation	NULL
and	NULL
binding	NULL
affinity	NULL
for	NULL
CD14	NULL
are	NULL
enhanced	NULL
by	NULL
the	NULL
LPS-binding	NULL
protein	NULL
(	NULL
7	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
PGN	NULL
and	NULL
LPS	NULL
induce	NULL
differential	NULL
activation	NULL
of	NULL
MAP	NULL
kinases	NULL
,	NULL
with	NULL
LPS	NULL
strongly	NULL
inducing	NULL
all	NULL
three	NULL
families	NULL
of	NULL
kinases	NULL
(	NULL
ERK	NULL
,	NULL
JNK	NULL
,	NULL
and	NULL
p38	NULL
)	NULL
,	NULL
but	NULL
with	NULL
PGN	NULL
only	NULL
inducing	NULL
ERK	NULL
and	NULL
JNK	NULL
,	NULL
but	NULL
not	NULL
p38	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
soluble	NULL
CDI4LPS	NULL
complexes	NULL
activate	NULL
CD14-negative	NULL
cells	NULL
,	NULL
whereas	NULL
soluble	NULL
CD14PGN	NULL
complexes	NULL
do	NULL
not	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Despite	NULL
these	NULL
differences	NULL
,	NULL
in	NULL
this	NULL
study	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
differences	NULL
between	NULL
PGN	NULL
and	NULL
LPS	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
CREB/	NULL
ATF	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
current	NULL
and	NULL
previous	NULL
(	NULL
8	NULL
)	NULL
results	NULL
indicate	NULL
that	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
,	NULL
CREB/ATE-1	NULL
,	NULL
and	NULL
AP-1	NULL
are	NULL
either	NULL
induced	NULL
by	NULL
CD14-dependent	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
are	NULL
common	NULL
for	NULL
PGN	NULL
and	NULL
LPS	NULL
,	NULL
or	NULL
that	NULL
different	NULL
pathways	NULL
activated	NULL
by	NULL
PGN	NULL
and	NULL
LPS	NULL
converge	NULL
to	NULL
activate	NULL
these	NULL
three	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Such	NULL
a	NULL
convergence	NULL
of	NULL
initially	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
to	NULL
activate	NULL
the	NULL
same	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
cells	NULL
through	NULL
cytokine	NULL
receptors	NULL
,	NULL
e.g	NULL
.	NULL

IL-1	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
88	NULL
)	NULL
.	NULL

The	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
through	NULL
which	NULL
PGN	NULL
and	NULL
LPS	NULL
activate	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
are	NULL
still	NULL
not	NULL
clear	NULL
.	NULL

Activation	NULL
of	NULL
AP-1	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
strong	NULL
activation	NULL
of	NULL
JNK	NULL
and	NULL
ERK1	NULL
and	NULL
ERK2	NULL
by	NULL
both	NULL
PGN	NULL
and	NULL
LPS	NULL
(	NULL
37	NULL
)	NULL
,	NULL
since	NULL
JNK	NULL
can	NULL
activate	NULL
c-Jun	NULL
and	NULL
both	NULL
JNK	NULL
and	NULL
ERK	NULL
can	NULL
induce	NULL
c-Fos	NULL
through	NULL
activation	NULL
of	NULL
ternary	NULL
complex	NULL
factor/Elk-1	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
possible	NULL
mechanism	NULL
of	NULL
activation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
are	NULL
less	NULL
clear	NULL
,	NULL
since	NULL
in	NULL
other	NULL
systems	NULL
the	NULL
main	NULL
mechanism	NULL
of	NULL
activation	NULL
of	NULL
ATF-1	NULL
and	NULL
CREB	NULL
is	NULL
through	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
but	NULL
we	NULL
could	NULL
not	NULL
show	NULL
any	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
by	NULL
PGN	NULL
or	NULL
LPS	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Other	NULL
possible	NULL
mechanisms	NULL
of	NULL
activation	NULL
could	NULL
involve	NULL
calmodulin	NULL
kinase	NULL
or	NULL
the	NULL
MAP	NULL
kinases	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
CREB/ATF	NULL
,	NULL
and	NULL
AP-1	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cytokine	NULL
genes	NULL
by	NULL
PGN	NULL
is	NULL
still	NULL
not	NULL
clear	NULL
.	NULL

As	NULL
seen	NULL
for	NULL
LPS	NULL
,	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
specific	NULL
genes	NULL
coding	NULL
for	NULL
pro-inflammatory	NULL
molecules	NULL
,	NULL
and	NULL
our	NULL
preliminary	NULL
data	NULL
indicate	NULL
that	NULL
NF-kB	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
ATF-1	NULL
,	NULL
but	NULL
not	NULL
AP-1	NULL
,	NULL
are	NULL
required	NULL
for	NULL
PGN-induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
TNF-a	NULL
.	NULL
``	NULL

These	NULL
transcription	NULL
factors	NULL
are	NULL
also	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
°	NULL
D.	NULL
Gupta	NULL
and	NULL
Q.	NULL
Wang	NULL
,	NULL
unpublished	NULL
observation	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
14020	NULL
induction	NULL
of	NULL
several	NULL
other	NULL
pro-inflammatory	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
in	NULL
PGN-activated	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
macrophages	NULL
by	NULL
PGN	NULL
leads	NULL
to	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
and	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
CD14-dependent	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Marc	NULL
R.	NULL
Montminy	NULL
for	NULL
providing	NULL
the	NULL
plasmid	NULL
A	NULL
(	NULL
-71	NULL
)	NULL
Som-CAT	NULL
and	NULL
to	NULL
Dr.	NULL
Michael	NULL
Karin	NULL
for	NULL
the	NULL
plasmids	NULL
2xAP1-Lue	NULL
,	NULL
-78Col-Lue	NULL
,	NULL
and	NULL
-60Col-Liue	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Schleifer	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
and	NULL
Kandler	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1972	NULL
)	NULL
Bacteriol	NULL
.	NULL

Rev	NULL
.	NULL

86	NULL
,	NULL
407-477	NULL
2	NULL
.	NULL

Heymer	NULL
,	NULL
B.	NULL
,	NULL
Seidl	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Schleifer	NULL
,	NULL
K.	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
in	NULL
Immunology	NULL
of	NULL
the	NULL
Bacterial	NULL
Cell	NULL
Envelope	NULL
(	NULL
Stewart-Tull	NULL
,	NULL
D.	NULL
E.	NULL
S.	NULL
,	NULL
and	NULL
Davies	NULL
,	NULL
M.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

11-46	NULL
,	NULL
John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
3	NULL
.	NULL

Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Ulmer	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Gupta	NULL
,	NULL
D.	NULL
(	NULL
1999	NULL
)	NULL
in	NULL
Glycomicrobiology	NULL
(	NULL
Doyle	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
ed	NULL
)	NULL
Plenum	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
in	NULL
press	NULL
4	NULL
.	NULL

Raetz	NULL
,	NULL
C.	NULL
R.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

59	NULL
,	NULL
129-170	NULL
5	NULL
.	NULL

De	NULL
Kimpe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kengatharan	NULL
,	NULL
M.	NULL
,	NULL
Thiemermann	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Vane	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
10359-10868	NULL
.	NULL

Gupta	NULL
,	NULL
D.	NULL
,	NULL
Jin	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Dziarski	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
2620-2630	NULL
.	NULL

Weidemann	NULL
,	NULL
B.	NULL
,	NULL
Brade	NULL
,	NULL
H.	NULL
,	NULL
Rietschel	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Bazil	NULL
,	NULL
V.	NULL
,	NULL
Kusumoto	NULL
,	NULL
S.	NULL
,	NULL
Flad	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
and	NULL
Ulmer	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

62	NULL
,	NULL
4709-4715	NULL
8	NULL
.	NULL

Gupta	NULL
,	NULL
D.	NULL
,	NULL
Kirkland	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Viriyakosol	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Dziarski	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
28310-28316	NULL
9	NULL
.	NULL

Weidemann	NULL
,	NULL
B.	NULL
,	NULL
Schletter	NULL
,	NULL
J.	NULL
,	NULL
Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Kusumoto	NULL
,	NULL
S.	NULL
,	NULL
Stelter	NULL
,	NULL
F.	NULL
,	NULL
Rietschel	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Flad	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
and	NULL
Ulmer	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

65	NULL
,	NULL
858-864	NULL
10	NULL
.	NULL

Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Tapping	NULL
,	NULL
R.	NULL
L	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
278	NULL
,	NULL
8680-8690	NULL
11	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1481-1483	NULL
12	NULL
.	NULL

Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
125-130	NULL
13	NULL
.	NULL

Hailman	NULL
,	NULL
E.	NULL
,	NULL
Lichenstein	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Wurefel	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Johnson	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Kelly	NULL
,	NULL
M.	NULL
,	NULL
Busse	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Zukowski	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
269-277	NULL
14	NULL
.	NULL

Viriyakosol	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kirkland	NULL
,	NULL
T.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
361-368	NULL
15	NULL
.	NULL

Juan	NULL
,	NULL
T.	NULL
S.	NULL
C.	NULL
,	NULL
Kelly	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Johnson	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Busse	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Hailman	NULL
,	NULL
E.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
and	NULL
Lichenstein	NULL
,	NULL
H.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1882-1387	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Bacterial	NULL
Peptidoglycan	NULL
Activates	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
.	NULL

Jin	NULL
,	NULL
Y.	NULL
,	NULL
Gupta	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Dziarski	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

177	NULL
,	NULL
1629-1638	NULL
.	NULL

Brindle	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
199-204	NULL
.	NULL

Xing	NULL
,	NULL
J.	NULL
,	NULL
Ginty	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
959-968	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
Liu	NULL
,	NULL
Z.-G.	NULL
,	NULL
and	NULL
Zandi	NULL
,	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9	NULL
,	NULL
240-246	NULL
.	NULL

Rosenthal	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Dziarski	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

285	NULL
,	NULL
253-285	NULL
.	NULL

Dziarski	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
4718-4718	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
John	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Sevarino	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Wagner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mandel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
6682-6686	NULL
.	NULL

Abn	NULL
,	NULL
S.	NULL
,	NULL
Olive	NULL
,	NULL
M.	NULL
,	NULL
Aggarwal	NULL
,	NULL
S.	NULL
,	NULL
Krylov	NULL
,	NULL
D.	NULL
,	NULL
Ginty	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
Vinson	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
967-977	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
479-490	NULL
Olive	NULL
,	NULL
M.	NULL
,	NULL
Krylov	NULL
,	NULL
D.	NULL
,	NULL
Eichlin	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Gardner	NULL
,	NULL
K.	NULL
,	NULL
Taparowsky	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Vinson	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
18586-18594	NULL
Chandra	NULL
,	NULL
G.	NULL
,	NULL
Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Godlevski	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Stinnett	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Noel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Kadwell	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Kost	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Gray	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
4535-4543	NULL
Fujihara	NULL
,	NULL
M.	NULL
,	NULL
Muroi	NULL
,	NULL
M.	NULL
,	NULL
Muroi	NULL
,	NULL
Y.	NULL
,	NULL
Ito	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
14898-14905	NULL
.	NULL

Yao	NULL
,	NULL
J.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Edgington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Fan	NULL
,	NULL
S.-T.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
17795-17801	NULL
Proffitt	NULL
,	NULL
J.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
,	NULL
Grove	NULL
,	NULL
M.	NULL
,	NULL
Daubersies	NULL
,	NULL
P.	NULL
,	NULL
Bailleul	NULL
,	NULL
B.	NULL
,	NULL
Wright	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Plumb	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

152	NULL
,	NULL
173-179	NULL
Pan	NULL
,	NULL
J.	NULL
,	NULL
Xia	NULL
,	NULL
L.	NULL
,	NULL
Yao	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
McEver	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
10068-10077	NULL
Gray	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Chandra	NULL
,	NULL
G.	NULL
,	NULL
Clay	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Stinnett	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Haneline	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Lorenz	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Patel	NULL
,	NULL
I.	NULL
R.	NULL
,	NULL
Wisely	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
Furdon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kost	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
6678-6689	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
Cambi	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Alam	NULL
,	NULL
J.	NULL
,	NULL
Otterbein	NULL
,	NULL
L.	NULL
,	NULL
Sylvester	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Choi	NULL
,	NULL
A.	NULL
M.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Resp	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
887-398	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Soldau	NULL
,	NULL
K.	NULL
,	NULL
Kline	NULL
,	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Kato	NULL
,	NULL
K.	NULL
,	NULL
Martin	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
8011-3021	NULL
Dziarski	NULL
,	NULL
R.	NULL
,	NULL
Jin	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Gupta	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

174	NULL
,	NULL
777-785	NULL
Kirschning	NULL
,	NULL
C.	NULL
,	NULL
Wesche	NULL
,	NULL
H.	NULL
,	NULL
Ayres	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Rothe	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
,	NULL
2091-2097	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16483-16486	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Bacterial	NULL
Peptidoglycan	NULL
Induces	NULL
CD14-dependent	NULL
Activation	NULL
of	NULL
Transcription	NULL
Factors	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
Dipika	NULL
Gupta	NULL
,	NULL
Qiuling	NULL
Wang	NULL
,	NULL
Charles	NULL
Vinson	NULL
and	NULL
Roman	NULL
Dziarski	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:14012-14020.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.20.14012	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/20/14012	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
36	NULL
references	NULL
,	NULL
26	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
401	NULL
2.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

